US Stock MarketDetailed Quotes

ERAS Erasca

Watchlist
  • 1.880
  • 0.0000.00%
Close Apr 25 16:00 ET
  • 1.940
  • +0.060+3.19%
Post 18:30 ET
284.81MMarket Cap-2265P/E (TTM)

About Erasca Company

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.

Company Profile

SymbolERAS
Company NameErasca
Listing DateJul 16, 2021
Issue Price16.00
Founded2018
CEODr. Jonathan E. Lim,M.D.
MarketNASDAQ
Employees126
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3115 Merryfield Row,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-465-6511
Websitehttp://www.erasca.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jonathan E. Lim,M.D.
  • Chairman of the Board and Chief Executive Officer
  • 7.52M
  • Dr. David M. Chacko
  • Chief Financial Officer and Principal Accounting Officer
  • 3.66M
  • Dr. Shannon Morris, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Michael D. Varney, PhD
  • Director
  • 314.13K
  • Dr. James A. Bristol, PhD
  • Independent Director
  • 207.91K
  • Pratik S. Multani, M.D.
  • Independent Director
  • 197.91K
  • Dr. Julie Hambleton, M.D.
  • Independent Director
  • 206.41K
  • Jean I. Liu
  • Independent Director
  • 520.09K
  • Dr. Valerie Harding Start, PhD
  • Independent Director
  • 206.91K
  • Bihua Chen
  • Independent Director
  • 201.41K
  • Alexander W. Casdin
  • Independent Director
  • 208.91K
  • Ebun S. Garner
  • General Counsel and Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg